calendar
4,758 catalysts · 4,590 phase readout · 2,336 8k filing · 285 earnings · 172 phase 2 completion · 162 pdufa · 73 phase 1 completion
4,758 catalysts · 4,590 phase readout · 2,336 8k filing · 285 earnings · 172 phase 2 completion · 162 pdufa · 73 phase 1 completion
Sponsor: University of Miami. Phase: . Conditions: Diabetes Mellitus, Type 1
Sponsor: Servicio de Salud Metropolitano Sur Oriente. Phase: PHASE2. Conditions: Rectal Cancer
Sponsor: Amgen. Phase: PHASE1. Conditions: Prostate Cancer
Sponsor: Johns Hopkins University. Phase: PHASE2. Conditions: Food Hypersensitivity
Sponsor: Methodist Health System. Phase: . Conditions: Frailty, Sarcopenia, COVID-19
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Healthy Adult Trial Participants
Sponsor: St. Pölten University of Applied Sciences. Phase: NA. Conditions: Osteo Arthritis Knee
Sponsor: Ain Shams University. Phase: NA. Conditions: We Are Studying the Effects of Caudal Dexamethasone in Neonates Undergoing Inguinal Hernia Repair
Sponsor: University of Pennsylvania. Phase: PHASE1. Conditions: Brain Tumor, Primary, Brain Tumor, Recurrent
Sponsor: Xinqiao Hospital of Chongqing. Phase: EARLY_PHASE1. Conditions: EBV-associated Tumors
Sponsor: Fauji Foundation Hospital. Phase: . Conditions: Traumatic Spinal Cord Injury
Sponsor: Atom Therapeutics Co., Ltd. Phase: PHASE1. Conditions: Gout Chronic, Gout, DDI (Drug-Drug Interaction)
Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumor
Sponsor: Berivan Beril Kılıç. Phase: . Conditions: Multiple Sclerosis, Pelvic Floor Dysfunction
Sponsor: Massachusetts General Hospital. Phase: EARLY_PHASE1. Conditions: Arginine Vasopressin Deficiency, Oxytocin Deficiency, Pediatric Disease, Hypopituitarism
Sponsor: Poitiers University Hospital. Phase: NA. Conditions: Oxygen Inhalation Therapy Endoscopy
Sponsor: Daniel B. F. Saris. Phase: PHASE1. Conditions: Cartilage Defect
Sponsor: Yonsei University. Phase: PHASE2. Conditions: Carcinoma, Small Cell Lung
Sponsor: Akyso Therapeutics, LLC. Phase: PHASE1. Conditions: Opioid Use Disorder
Sponsor: Amgen. Phase: PHASE1. Conditions: Atopic Dermatitis
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Decision Support System, Outcome
Sponsor: University of Alberta. Phase: PHASE1. Conditions: Migraine, Headache
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Osteogenesis Imperfecta, Short Stature
Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: . Conditions: Cerebral Palsy (CP), Typically Developing Children
Sponsor: National Institute on Drug Abuse (NIDA). Phase: PHASE2. Conditions: Addiction, Alcohol Use Disorder
Sponsor: St George's, University of London. Phase: NA. Conditions: Spinal Cord Injuries
Sponsor: SB Istanbul Education and Research Hospital. Phase: NA. Conditions: Total Knee Arthroplasty, Ultrasound Guided Supra-inguinal Fascia Iliaca Block, Adductor Canal Block
Sponsor: Sun Yat-sen University. Phase: NA. Conditions: Head and Neck Squamous Cell Carcinoma (HNSCC)
Sponsor: University of Alabama at Birmingham. Phase: . Conditions: Opioid Use Disorder, Sleep Disturbance
Sponsor: Central South University. Phase: NA. Conditions: Schizophrenia Disorder, Cognitive Impairments
Sponsor: Radboud University Medical Center. Phase: PHASE2. Conditions: Prostate Cancer
Sponsor: Yu-fan Li. Phase: NA. Conditions: Overweight , Obesity
Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Breast Cancer
Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Congenital Neutropenia
Sponsor: University Hospital, Antwerp. Phase: . Conditions: Benign Pancreas Tumor, Malignant Pancreatic Neoplasm
Sponsor: University of Turin, Italy. Phase: NA. Conditions: Peri-implant Mucositis
Sponsor: Nordsjaellands Hospital. Phase: . Conditions: Orthopedic Disorder
Sponsor: Beijing Anzhen Hospital. Phase: NA. Conditions: AF - Atrial Fibrillation, ICH - Intracerebral Hemorrhage
Sponsor: Boston Children's Hospital. Phase: . Conditions: Congenital Heart Disease
Sponsor: 89bio, Inc.. Phase: PHASE3. Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Sponsor: Genfit. Phase: PHASE1. Conditions: Acute-on-Chronic Liver Failure
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.. Phase: PHASE1. Conditions: Locally Advanced or Metastatic Solid Tumors
Sponsor: Tcelltech Inc.. Phase: PHASE1. Conditions: High-grade Glioma, WHO Grade Ⅳ Glioma
Sponsor: Stanford University. Phase: PHASE2. Conditions: Anterior Cruciate Ligament Reconstruction
Sponsor: Northwell Health. Phase: PHASE4. Conditions: Psychosis; Acute
Sponsor: Agri Ibrahim Cecen University. Phase: NA. Conditions: Pediatric Wounds, Procedural Pain, Procedure-Related Anxiety, Procedural Fear
Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Vascular And Immunologic Diseases, Healthy Volunteers
Sponsor: Assaf-Harofeh Medical Center. Phase: NA. Conditions: Anterior Cruciate Ligament Reconstruction
Sponsor: Bright Peak Therapeutics Inc. Phase: PHASE1. Conditions: Advanced Solid Tumors
Sponsor: Mayo Clinic. Phase: NA. Conditions: Neck Pain